Our website uses cookies to make navigation as functional as possible and to perform statistics on its usage. Should you wish to receive more information, or deny your consent to all or some of the cookies, please click here. By continuing to browse this website, you will be accepting our cookies.

VitaPCRTM platform



The VitaPCRTM SARS-CoV-2 Assay performed on the VitaPCRTM Instrument is a rapid molecular in vitro diagnostic test utilizing a real-time reverse transcription polymerase chain reaction (RT-PCR) amplification technology. It is used for the qualitative detection and discrimination of SARS-CoV-2 viral RNAs in direct nasopharyngeal (NP) or oropharyngeal (OP) swabs from patients with signs and symptoms of respiratory infection who are suspected of COVID-19.
br> The detection target of SARS-CoV-2 RNA is located in the region of the virus nucleocapsid (N) gene.
The assay is designed for specific detection of the SARS-CoV-2 RNA. In addition, detection of SARSlike (including SARS-CoV-2, SARS-CoV, bat SARS-like coronavirus) conserved region also located in N gene is provided as additional information for reference. An additional primer/probe set to detect human Beta-globin (HBB), which is also used as a sample adequacy control (SAC), is included in the reagent for ensuring adequate addition of sample and monitoring the presence of inhibition factors in the PCR process.